PIN48 Cost-Efectiveness Analysis of Darunavir Versus Atazanavir, Each in Combination With Emtricitabine and Tenofovir, for the Management of Naive Anti-Retroviral HIV Infected Patients, Under the Belgian Social Security Perspective
Abstract
Authors
M. Santos S. Stenut W. Ferraq J.C. Legrand P. Tilleul I. Borget